MEDITULIP developed a novel asymmetrical linear stapler (NALS) that enables surgeons to take tissue samples for frozen section biopsy from the true resection margin and to confirm the radicality of cancer surgery intraoperatively. MEDITULIP patented this technology and develops other medical devices to advance minimally invasive surgery. MEDITULIP is preparing for regulatory approval of its staplers in South Korea and other countries.
Publication: “Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue”, J Thorac Dis. 2018 Jun; 10(Suppl 14): S1631–S1636